Process for the manufacture of a pharmaceutical composition with a retarded liberation of active material

Claim 1

An improved process for the production of a pharmaceutical composition with a retarded liberation of active material, including active material which is unstable above 70° C., wherein the improvement comprises (a) mixing said active material and finely divided particle form with finely divided particles of high melting and a low melting lipid or lipoid component, in a weight ratio of 1:9 to 1 wherein the melting point of the high melting component is above 70° C. and the melting point of the low melting component is from about 30° C. to below about 70° C. wherein the lipid or lipoid component is a fatty alcohol, containing 13-20 carbon atoms or a mixture thereof, a fatty acid, a lipophilic stearate, a hydrogenated vegetable oil or mono-, di- and triester of glycerol with palmitic acid or stearic acid or mixtures thereof or a vegetable, animal, mineral or synthetic wax. (b) bringing the mixture to a temperature which is above the melting point of the low melting component but below the melting point of the high melting component thereby embedding particles of the high melting component and active material in the low melting component like gravel in concrete in cement and (c) after melting of the low melting component, allowing the mixture to cool below the melting point thereof. PG,20